Avoro Capital Advisors LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$6.4T
Holdings
43
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HZNPHORIZON THERAPEUTICS PLC | 9,000,000 | $985.9B | 15.49% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 5,000,000 | $884.5B | 13.89% | |
| 3 | XLRNACCELERON PHARMA INC | 4,476,100 | $688.4B | 10.81% | Call |
| 4 | UTHUNITED THERAPEUTICS CORP | 3,000,000 | $553.7B | 8.70% | |
| 5 | ASNDASCENDIS PHARMA | 1,980,000 | $315.6B | 4.96% | |
| 6 | ARGXARGENX SE | 946,500 | $285.8B | 4.49% | |
| 7 | SRPTSAREPTA THERAPEUTICS INC | 2,700,000 | $233.4B | 3.67% | Call |
| 8 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,150,000 | $211.2B | 3.32% | Call |
| 9 | ARNAEURARENA PHARMACEUTICALS INC | 3,425,000 | $204.0B | 3.20% | |
| 10 | AM6AMICUS THERAPEUTICS INC | 17,679,273 | $168.8B | 2.65% | |
| 11 | APLSAPELLIS PHARMACEUTICALS INC | 6,515,000 | $166.1B | 2.61% | Call |
| 12 | ALNYALNYLAM PHARMACEUTICALS INC | 850,000 | $160.5B | 2.52% | |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,875,000 | $144.9B | 2.28% | |
| 14 | VRTXVERTEX PHARMACEUTICALS INC | 664,000 | $120.4B | 1.89% | |
| 15 | OPHTEURIVERIC BIO INC | 7,100,000 | $115.3B | 1.81% | |
| 16 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,425,000 | $113.7B | 1.79% | |
| 17 | TREURTRILLIUM THERAPEUTICS INC | 5,700,000 | $100.1B | 1.57% | |
| 18 | PMVPPMV PHARMACEUTICALS INC | 2,925,000 | $87.2B | 1.37% | |
| 19 | KURAKURA ONCOLOGY INC | 4,000,000 | $74.9B | 1.18% | |
| 20 | —MERSANA THERAPEUTICS INC | 6,800,000 | $64.1B | 1.01% | |
| 21 | GLUEMONTE ROSA THERAPEUTICS INC | 3,311,434 | $61.0B | 0.96% | |
| 22 | XENEXENON PHARMACEUTICALS INC | 3,650,000 | $55.8B | 0.88% | |
| 23 | WHWKAADI BIOSCIENCES INC | 1,829,402 | $53.7B | 0.84% | |
| 24 | MNKDMANNKIND CORP | 8,800,000 | $38.3B | 0.60% | |
| 25 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $37.6B | 0.59% | |
| 26 | MRNS*MARINUS PHARMACEUTICALS INC | 3,235,000 | $36.8B | 0.58% | |
| 27 | ACADACADIA PHARMACEUTICALS INC | 2,200,000 | $36.5B | 0.57% | |
| 28 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 1,068,000 | $36.3B | 0.57% | |
| 29 | AMRNAMARIN CORP PLC | 6,000,000 | $30.6B | 0.48% | |
| 30 | PRAXPRAXIS PRECISION MEDICINES INC | 1,600,000 | $29.6B | 0.46% | |
| 31 | SNDXSYNDAX PHARMACEUTICALS INC | 1,545,000 | $29.5B | 0.46% | |
| 32 | RNAAVIDITY BIOSCIENCES INC | 1,150,000 | $28.3B | 0.44% | |
| 33 | KYMRKYMERA THERAPEUTICS INC | 455,750 | $26.8B | 0.42% | |
| 34 | —DICE THERAPEUTICS INC | 800,000 | $26.2B | 0.41% | |
| 35 | BIIBBIOGEN INC | 84,000 | $23.8B | 0.37% | |
| 36 | AVDLAVADEL PHARMACEUTICALS PLC | 2,275,000 | $22.3B | 0.35% | |
| 37 | NUVLNUVALENT INC | 1,257,671 | $22.3B | 0.35% | |
| 38 | DSGNDESIGN THERAPEUTICS INC | 1,468,318 | $21.6B | 0.34% | |
| 39 | TNGXTANGO THERAPEUTICS INC | 1,550,000 | $20.0B | 0.31% | |
| 40 | FRXFENNEC PHARMACEUTICALS INC | 1,670,000 | $15.7B | 0.25% | |
| 41 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $15.1B | 0.24% | |
| 42 | MRUSMERUS N V | 450,000 | $9.9B | 0.16% | |
| 43 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $9.8B | 0.15% |